| Patient | Frederick Law Olmsted |
|---|---|
| Date of birth | 1822-04-26 |
| Identifiers | MRN HR-NI022-SYN-TD; SSN (made up) 000-22-5519 |
| Document date | 1895-09-15 |
| Author | Nathan Calder, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Subsequent annual wellness visit; no new complaints. [S]
Mr. Olmsted is a 73-year-old man with mild dementia of undetermined type who returns with his caregiver for his subsequent annual wellness visit, six weeks after his three-month dementia review. He answered the health risk assessment himself, with his caregiver reading the questions and adding what he could not recall. His cold in July cleared in two weeks, and he has had no further night-time confusion since the antihistamine was stopped. He takes donepezil 10 mg each morning, given by his caregiver from a weekly organizer, with no nausea, diarrhea, dizziness, or vivid dreams. He no longer drives. He walks most days with company and goes to an adult day program twice a week, which he enjoys for the gardens. He has had no falls, emergency visits, or hospital stays this year. [S]
| Element | Detail |
|---|---|
| Visit | Subsequent annual wellness visit |
| Context | Health risk assessment answered by the patient with caregiver help because of dementia |
| Safety events | No falls, emergency visits, or hospital stays this year |
| Medicines | Donepezil 10 mg daily from a weekly organizer; no over-the-counter medicines since the cold |
| Active conditions | Mild dementia of undetermined type, CDR 1 |
| Functional status | Independent in basic activities of daily living; needs help with finances, medicines, and travel |
Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]
| Domain | Finding |
|---|---|
| How completed | Answered by the patient with his caregiver reading the questions and adding what he could not recall |
| Self-rated health | Good, in his words |
| Psychosocial | Lives at home with family; adult day program twice a week; misses his work but enjoys the gardens and visitors |
| Tobacco | Never used tobacco |
| Alcohol | None since the first visit (AUDIT-C 0) |
| Physical activity | Walks 30 to 45 minutes most days with company |
| Nutrition | Three regular meals; weight stable over the past three months |
| Sleep | Sleeps through most nights; no sleep medicines |
| Activities of daily living | Independent in bathing, dressing, toileting, and eating |
| Instrumental activities of daily living | Caregiver manages medicines, bill paying, and transport, with his agreement |
| Home safety | No firearms in the home; medicines kept locked; night lights in place; smoke detectors working |
| Falls | No falls this year |
| Hearing and vision | No hearing concern; reading glasses; no eye examination in the past two years |
| Memory | Known mild dementia; his caregiver notices no change since the spring |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight stable over three months; no fever or new fatigue |
| Eyes | Negative | No change in vision with reading glasses |
| Ears, nose, mouth, and throat | Negative | Cold resolved; no hearing difficulty in conversation |
| Cardiovascular | Negative | No chest pain, fainting, or lightheadedness on donepezil |
| Respiratory | Negative | Cough resolved; no breathlessness |
| Gastrointestinal | Negative | No nausea, diarrhea, or loss of appetite on donepezil |
| Genitourinary | Negative | Gets up once a night to pass urine; no incontinence |
| Musculoskeletal | Negative | No joint pain or falls |
| Integumentary | Negative | No new or changing skin lesions |
| Neurological | Positive | Known memory loss, unchanged by his caregiver's account; no night-time confusion since the antihistamine was stopped |
| Psychiatric | Negative | Mood fair to good; no hallucinations or agitation; PHQ-2 score 1 |
| Endocrine | Negative | No thirst or frequent urination |
12 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Donepezil 5 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning with breakfast | Oral route | 1895-06-02 to 1895-08-04 | completed | S |
| Donepezil 10 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning with breakfast | Oral route | 1895-08-04 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1895-09-15 | Body height | 175 | cm | S |
| 1895-09-15 | Body weight | 71 | kg | S |
| 1895-09-15 | Body mass index (BMI) [Ratio] | 23.2 | kg/m2 | S |
| 1895-09-15 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1895-09-15 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1895-09-15 | Heart rate | 60 | /min | S |
| 1895-09-15 | Respiratory rate | 14 | /min | S |
| 1895-09-15 | Body temperature | 36.6 | Cel | S |
| 1895-09-15 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1895-09-15 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 1895-09-15 | Total score [AUDIT-C] | 0 | {score} | S | ||
| 1895-09-15 | Cholesterol [Mass/volume] in Serum or Plasma | 196 | mg/dL | <=200 mg/dL | Normal | S |
| 1895-09-15 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 54 | mg/dL | >=40 mg/dL | Normal | S |
| 1895-09-15 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 118 | mg/dL | <=129 mg/dL | Normal | S |
| 1895-09-15 | Triglyceride [Mass/volume] in Serum or Plasma | 120 | mg/dL | <=149 mg/dL | Normal | S |
Vital signs recorded on 1895-09-15; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Alert, courteous, and well groomed; weight 71.0 kg, BMI 23.2 |
| Eyes | Pupils equal and reactive; near vision 20/30 with reading glasses |
| Ears | Canals clear; whispered-voice test passed in both ears |
| Neck | No thyroid enlargement or nodes; no carotid bruits |
| Cardiovascular | Regular rhythm at 60 per minute; no murmur; no edema; blood pressure 128/74 mmHg |
| Respiratory | Clear to auscultation bilaterally |
| Abdomen | Soft and non-tender; no masses or aortic pulsation |
| Musculoskeletal | Timed Up and Go 11 seconds; rises from a chair without using his arms |
| Neurological | Oriented to person and place, not to date; repeats a question once; no focal weakness; normal gait. Cognition assessed by direct observation and the established diagnosis |
| Psychiatric | Pleasant and engaged; no agitation |
| Skin | Weathered skin on the face and hands; no suspicious lesions |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Mild dementia (major neurocognitive disorder), progressive, amnestic-predominant with executive difficulty, type undetermined; CDR global 1 | active | confirmed | F03.A0 | S — Synthetic modern coding of his documented failing memory; the cause is unknown, so the type is left unspecified. Stage and scores are synthetic. |
| Common cold, with two nights of increased confusion after an over-the-counter nighttime cold medicine containing diphenhydramine; resolved | resolved | confirmed | J00 | S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness. |
| Progressive memory loss over about two years with decline in managing his work and affairs, under evaluation for dementia or mild cognitive impairment | resolved | confirmed | R41.3 | S — Synthetic presenting concern at the index visit, superseded by the dementia diagnosis at the four-week visit; the failing memory is documented (D). |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Influenza vaccine, this season | Completed today | High-dose vaccine given today |
| Pneumococcal vaccine | Completed today | PCV20 given today; no further doses needed |
| Recombinant zoster vaccine | Completed today | Dose 1 given today; dose 2 due in two to six months |
| COVID-19 vaccine, this season | Due | Recommended at his age; his caregiver will arrange it at the pharmacy |
| RSV vaccine | Not indicated | Recommended at 75 and older, and from 50 with conditions that raise risk; he has none. Review at 75 |
| Tetanus, diphtheria, and pertussis booster | Due | No dose on record in the past ten years; to be given with the second zoster dose |
| Depression screening | Completed today | PHQ-2 score 1; PHQ-9 continues at the dementia reviews |
| Alcohol misuse screening | Completed today | AUDIT-C score 0 |
| Cognitive assessment | Completed today | Direct observation in established mild dementia; MoCA 19 at diagnosis, repeated yearly on the CMID schedule |
| Falls prevention | Completed today | Timed Up and Go 11 seconds; no falls; daily walking continues |
| Hearing | Completed today | Whispered-voice test passed in both ears; hearing loss would worsen cognition, so it will be rechecked yearly |
| Eye examination | Due | No eye examination in the past two years; his caregiver will book one |
| Cholesterol screening and statin decision | Completed today | Total cholesterol 196, HDL 54, LDL 118, triglycerides 120 mg/dL. Ten-year risk about 18 percent from age alone, without diabetes, hypertension, dyslipidemia, or smoking, so the USPSTF criteria for a statin are not met. A statin was discussed; he prefers no new daily medicine, and his caregiver agrees |
| Diabetes screening | Not indicated | Recommended for overweight adults 35 to 70; BMI 23.2, and glucose was normal in May |
| Colorectal cancer screening | Ordered | No screening on record in the past ten years; at 73 with mild dementia and good health, he chose a fecal immunochemical test, and a kit was given to his caregiver today |
| Prostate cancer screening | Not indicated | PSA screening is not recommended at 70 and older |
| Hepatitis C screening | Ordered | One-time screening recommended for adults 18 to 79; no result on record; drawn with today's blood tests with his consent |
| Lung cancer and abdominal aortic aneurysm screening | Not indicated | Never used tobacco |
| Advance care planning | Up to date | Health care agent named and his wishes recorded six weeks ago; reviewed today without change |
Immunizations given today: High-dose influenza vaccine, 1895-1896 season; Pneumococcal conjugate vaccine PCV20; Recombinant zoster vaccine, dose 1 of 2 [S]
Guideline basis: CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Alzheimer's disease monographs (2026); Medicare Wellness Visits (Medicare Learning Network) (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)
Follow-up: Six-month dementia review in about six weeks. Second zoster dose and the Tdap booster in two to six months. Return the stool test kit within two weeks; the hepatitis C result will be sent by letter. Next annual wellness visit in one year. Next scheduled visit 1895-10-27: six-month dementia review. [S]
The advance care planning completed six weeks ago was reviewed with him and his caregiver. His health care agent remains the same and is recorded in the chart, not named here. He confirmed that what matters most to him is staying at home among gardens and trees for as long as it is safe, and being told the truth about his condition. No decisions were changed. The plan will be revisited at the yearly dementia review and at any change in stage. [S]